Company news
Alembic Pharmaceuticals Limited (NSE:APLLTD) news
Alembic Pharmaceuticals Limited news releases on 6ix. Latest, Nov 9, 2020: Press Release Nov 09 2020
Press releases — page 4
Press Release Nov 09 2020
November 9, 2020
Press Release Oct 26 2020
October 26, 2020
Press Release Oct 22 2020
October 22, 2020
Press Release Oct 21 2020
October 21, 2020
Press Release Oct 16 2020
October 16, 2020
Press Release Oct 13 2020
October 13, 2020
Press Release Sep 07 2020
September 7, 2020
Press Release Aug 27 2020
August 27, 2020
Press Release Aug 25 2020
August 25, 2020
Press Release Aug 13 2020
August 13, 2020
Press Release Aug 05 2020
August 5, 2020
Alembic Pharmaceuticals : Press Release USFDA Approval Doxycycline Capsules USP
July 31, 2017
Alembic Pharmaceuticals : Press Release April
July 21, 2017
Alembic Pharmaceuticals : Press Release USFDA Approval Olmesartan Medoxomil & Amlodipine Tablets
July 18, 2017
Alembic Pharmaceuticals : Press Release USFDA Tentative Approval Vardenafil Hydrochloride Orally Disintegrating Tablets
July 5, 2017
Alembic Pharmaceuticals : Press Release USFDA Approval Amantadine Hydrochloride Capsules USP
June 22, 2017
Alembic Pharmaceuticals : Press Release USFDA Approval Fenofibric Acid Delayed-Release Capsules
May 15, 2017
Alembic Pharmaceuticals : Press Release January
May 3, 2017
Alembic Pharmaceuticals : Press Release USFDA Approval Fluoxetine Hydrochloride Tablets
April 19, 2017
Alembic Pharmaceuticals : Press Release USFDA Tentative Approval Vilazodone Tablets
April 19, 2017
Alembic Pharmaceuticals : Press Release Successful USFDA Inspection Bioequivalence
April 19, 2017